References

  1. Braman SS. The Global Burden of Asthma. Chest. 2006;130(1 Suppl):4S-12S. PubMed | Google Scholar

  2. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, Robertson C; ISAAC Phase Three Study Group.Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007;62(9):758-66. PubMed | Google Scholar

  3. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992;326(13):862-6. PubMed | Google Scholar

  4. Weiss KB, Sullivan SD. The economic costs of asthma: a review and conceptual model. Pharmacoeconomics. 1993;4(1):14-30. PubMed | Google Scholar

  5. Global Initiative for Asthma. GINA workshop report: global strategy for asthma management and prevention. Available at: http://www.ginasthma.com/.Access on September 2014). PubMed | Google Scholar

  6. Ringdal N, Derom E, Wahlin-Boll E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler®. Respir Med. 1998;92(8):1017-1021. PubMed | Google Scholar

  7. Seberová E, Andersson A. Oxis® (formoterol given via Turbuhaler ®) showed as rapid an onset of action as salbutamol given by pMDI. Respir Med. 2000;94(6):607-611. PubMed | Google Scholar

  8. Zetterström, Buhl R, Mellem H, Andersson F. The whole story: treatment outcomes with BFT. Respir Med. 2002;96 Suppl A:S29-35. PubMed | Google Scholar

  9. Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, Ekström T, Selroos O. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. Curr Med Res Opin. 2006;22(5):809-21. PubMed | Google Scholar

  10. Abdelhamid E, Awad A, Gismallah A. Evaluation of a hospital pharmacy-based Pharmaceutical care services for asthma patients. Pharmacy Practice. 2008;6(1):25-32. PubMed | Google Scholar

  11. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med. 2006;174(2):112-9. PubMed | Google Scholar

  12. Patterson PE, Harding SM. Gastroesophageal reflux disorders and asthma. Curr Opin Pulm Med. 1999;5(1):63-7. PubMed | Google Scholar

  13. Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med. 2000;162(1):34-9. PubMed | Google Scholar

  14. Harish Babu BN, Mahesh PA, Venkatesh YP. A cross-sectional study on the prevalence of food allergy to eggplant (Solanum melongena L) reveals female predominance. Clin Exp Allergy. 2008; 38(11):1795-802. PubMed | Google Scholar

  15. Pramod SN, Venkatesh YP. Allergy to eggplant (Solanum melongena) caused by a putative secondary metabolite. J Investig Allergol Clin Immunol. 2008;18(1):59-62. PubMed | Google Scholar

  16. Folli C, Descalzi D, Scordamaglia F, Riccio AM, Gamalero C, Canonica GW. New insights into airway remodelling in asthma and its possible modulation. Curr Opin Allergy Clin Immunol. 2008;8(5):367-75. PubMed | Google Scholar

  17. Sumi Y, Hamid Q. Airway remodeling in asthma. Allergol Int. 2007;56(4):341-8. PubMed | Google Scholar

&